Skip to main content

Table 3 Diagnostic work-up and antibiotic prescription in FLUTDa cases presented to university hospitals or private practices

From: Antimicrobial use for selected diseases in cats in Switzerland

Parameter

 

University hospitals

Private practices

p-value

Total number of cases

 

n = 130

n = 203

 

Urine analysis performed

Yesb

119 (92%)

55 (27%)

<0.001

  Sediment analysis

Yesb

93 (72%)

50 (25%)

<0.001

  Bacterial culture

Yesb

113 (87%)

20 (10%)

<0.001

Confirmed bacterial etiologyc

Yesb

45 (35%)

16 (8%)

<0.001

Hospitalization

Yesb

90 (69%)

30 (15%)

<0.001

Pre-treated with antibiotics

Yesb

23 (18%)

4 (2%)

<0.001

 

Unknown

5 (4%)

3 (2%)

 

Antibiotic therapy

Yesb

85 (65%)

115 (57%)

n.s.d

  Antibiotic classes

Potentiated aminopenicillins

71 (84%)

50 (57%)

<0.001

 

Third generation cephalosporins

7 (8%)

44 (38%)

<0.001

 

Fluoroquinolones

5 (6%)

20 (17%)

0.017

 

Aminopenicillins

1 (1%)

22 (19%)

<0.001

 

First generation cephalosporins

5 (6%)

1 (1%)

n.s.d

 

Amphenicols

1 (1%)

0 (0%)

n.s.d

 

Tetracyclines

1 (1%)

0 (0%)

n.s.d

  Combination or serial therapye

Yesb

6 (7%)

20 (17%)

n.s.d

  Critically important antibiotice

Yesb

12 (14%)

62 (54%)

<0.001

  Duration of therapy (days)

Median (range)

13 (1 ̶56)

9 (1 ̶42)

0.012

Justification scoree

1

57 (44%)

24 (12%)

<0.001

 

2

1 (1%)

0 (0%)

n.s.d

 

3

22 (17%)

9 (4%)

<0.001

 

4

39 (30%)

11 (6%)

<0.001

 

Judgement not possible

11 (8%)

159 (78%)

<0.001

  1. aFLUTD, feline lower urinary tract disease; bValues for the category “no” (reference group) are not shown; cDefined as either positive urine sediment analysis or positive bacterial culture; dn.s., not significant; eAs defined in methods